The hemodialysis and peritoneal dialysis market is expected to expand at a 6.59% CAGR, reaching USD 176.749 billion in 2031 from USD 120.545 billion in 2025.
Dialysis is done when the kidneys are unable to remove toxins from the blood. Hemodialysis is a common kind of blood-cleaning procedure that is carried out at any dialysis center three to five times each week. The hemodialysis access is in the patient's arm. Peritoneal dialysis is a type of continuous dialysis that cleans the peritoneal cavity in the abdomen each day to eliminate waste from the blood. It can be done at home. This is accessible through the abdomen. For chronic, or ongoing, dialysis, the patient can get hemodialysis or peritoneal dialysis.
Hemodialysis and peritoneal dialysis market growth prospects
The hemodialysis and peritoneal dialysis industry growth is attributed to a surge in kidney-related illnesses and concerns since kidney transplantation needs a major procedure, a donor match, and a lifetime regimen of immunosuppressant medications to prevent the organ from being rejected by the human body. Further supporting the expansion of the worldwide hemodialysis and peritoneal dialysis market is expected to be the rise in the incidence of chronic diseases and lifestyle-related illnesses, including obesity, diabetes, and hypertension. Hemodialysis and peritoneal dialysis industry development is constrained by comparable problems with reimbursement procedures in emerging nations.
Diabetes cases are rising
According to WHO estimates, adults living with diabetes were most prevalent in the Western Pacific (167 million), South Asia (88 million), and Europe (59 million) in 2021. ERD cases are rising in correlation with rising diabetes incidence. In addition, kidney problems are also caused by poor food, an unhealthy lifestyle, and a lack of physical activity. Lifestyle is responsible for 60% of health-related issues, including malnutrition, smoking, improper food, drug misuse, stress, and alcohol consumption. The aforementioned variables are causing ESRD instances to increase internationally.
Consumables are expected to account for a sizable portion of the industry
Throughout the projection period, the governments are anticipated to make large expenditures to improve patient safety, patient-centered treatment, and efficacy. Catheters composed of complex materials that are impervious to chemicals like peroxides, iodine, and alcohol are being produced by businesses. Similar to how better surface contact and cutoff membrane dialyzers are for higher diffusion, new production techniques for dialyzers have a positive effect on the expansion of the consumables, leading to the growth of the hemodialysis and peritoneal dialysis market. Bloodlines, concentrates, catheters, and other items have been added to the further division of the consumables market.
The dominance of hospital-based dialysis
The dominance of hospital-based dialysis is projected to remain strong in the upcoming years because there is a substantial supply of highly trained and experienced healthcare workers in hospitals. In healthcare settings like dialysis centers and hospitals, the presence of a qualified and skilled renal care team guarantees the best possible care and improved dialysis outcomes. A variety of factors, including the rivals' increased focus on creating independent dialysis facilities and patients' growing acceptance of in-center dialysis, are projected to cause the market to grow. Businesses are also focusing on developing customized hemodialysis equipment with a variety of interventions.
Technological developments
Major factors influencing the hemodialysis and peritoneal dialysis market growth in terms of revenue include technological advancements in dialysis equipment and growing public awareness of the benefits of these treatments. Hemodialysis machines with improved characteristics, including portability, usability, and dependability, are in high demand. The availability of hemodialysis technology for home use has increased patient satisfaction and offered patients greater independence. Peritoneal dialysis is also gaining popularity as a cost-effective and useful alternative for patients, even though it may be carried out at home without the need for specialized equipment. Additionally, the availability of automated peritoneal dialysis (APD) equipment is likely to fuel hemodialysis and peritoneal dialysis market growth.
Government regulations
Government regulations have been increasing globally, fueling the hemodialysis and peritoneal dialysis market growth. For instance, hemodialysis and peritoneal dialysis service providers are required to adhere to quality standards set by the Centers for Medicare & Medicaid Services (CMS). The Food and Drug Administration (FDA) of the United States establishes requirements for hemodialysis and peritoneal dialysis medical devices in terms of their quality, safety, efficacy, and labeling. Before being marketed in the European Union (EU), medical devices must pass several tests to guarantee their quality and safety under the EU Medical Device Directive. Additionally, in Japan, hemodialysis and peritoneal dialysis equipment must adhere to regulations imposed by the Ministry of Health, Labour, and Welfare (MHLW). China has enacted medical device laws that follow both international and domestic standards for hemodialysis and peritoneal dialysis equipment.
Hemodialysis and peritoneal dialysis markets are predicted to increase significantly in North America.
The hemodialysis and peritoneal dialysis market in the area is growing due to the presence of well-known manufacturers, major government expenditures in the development of cutting-edge medical devices, and a supportive reimbursement framework. The prevalence of dialysis is rising due to the rise in kidney failures and Chronic Kidney Disease (CKD). Increasing healthcare spending, government initiatives, and high disposable income are further factors promoting hemodialysis and peritoneal dialysis market development.
The Asia Pacific hemodialysis and peritoneal dialysis market is anticipated to grow
The hemodialysis and peritoneal dialysis market is anticipated to hold a significant market share in the Asia Pacific region during the projected period. Increased development of cutting-edge goods, an expanding elderly population, and rising occurrences of renal failure are predicted to promote hemodialysis and peritoneal dialysis market growth over the forecast period. In addition, the IDF estimates that 88 million individuals in Southeast Asia already have diabetes, with 153 million likely to have the disease by 2045. In addition, increased government initiatives, CKD awareness programs, technologically advanced goods, and the existence of recently built state-of-the-art healthcare facilities in the area are a few more factors influencing hemodialysis and peritoneal dialysis market growth.
November 2025: Lords Mark India acquired an 85% stake in Renalyx Health Systems, aiming to scale its AI-powered hemodialysis machine, RxT 21, and reach a 92% stake by March 2026.
November 2025: DaVita highlights advanced dialysis research on middle?molecule clearance at ASN Kidney Week 2025. DaVita presented clinical research at ASN Kidney Week focusing on innovations in dialysis treatment and improving patient outcomes through advanced therapy strategies.
October 2025: Fresenius Medical Care presents real-world hemodiafiltration and AI advances at ASN Kidney Week 2025. Fresenius researchers showcased clinical evidence of HDF benefits and AI support tools for clinicians at the major nephrology event.
June 2025: Renalyx Health Systems launches Indiaโs first indigenous AI-enabled smart hemodialysis machine, RxT 21. Renalyx introduced RxT 21, an AI-powered and cloud-enabled hemodialysis system to improve accessibility and affordability in renal care.
The Renal Project
DaVita
Fresenius Kidney Care
NephroPlus
NxStage
| Report Metric | Details |
|---|---|
| Study Period | 2021 to 2031 |
| Historical Data | 2021 to 2024 |
| Base Year | 2025 |
| Forecast Period | 2026 โ 2031 |
| Companies |
|
Report Metric | Details |
Hemodialysis and Peritoneal Dialysis Market Size in 2025 | USD 120.545 billion |
Hemodialysis and Peritoneal Dialysis Market Size in 2030 | USD 167.446 billion |
Growth Rate | CAGR of 6.79% |
Study Period | 2020 to 2030 |
Historical Data | 2020 to 2023 |
Base Year | 2024 |
Forecast Period | 2025 โ 2030 |
Forecast Unit (Value) | USD Billion |
Segmentation |
|
Geographical Segmentation | North America, South America, Europe, Middle East and Africa, Asia Pacific |
List of Major Companies in Hemodialysis and Peritoneal Dialysis Market |
|
Customization Scope | Free report customization with purchase |
By Type
Hemodialysis
Peritoneal dialysis
By Product
Device
Consumables
By End-User
Home-based
Hospital-based
By Geography
North America
United States
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
Germany
France
United Kingdom
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Others
Asia Pacific
China
India
Japan
South Korea
Indonesia
Thailand
Others